IGF2BP3 (IMP3) expression in angiosarcoma, epithelioid hemangioendothelioma, and benign vascular lesions

被引：0
|
作者：
Misuzu Okabayshi
Tatsuki R. Kataoka
Marina Oji
Satoko Mibayashi
Kentaro Odani
Atsushi Otsuka
Hironori Haga
机构：
[1] Kyoto University Hospital,Department of Diagnostic Pathology
[2] Kyoto University Hospital,Translational Research Department for Skin and Brain Diseases, Department of Dermatology
来源：
Diagnostic Pathology | / 15卷
关键词：
Angiosarcoma; Epithelioid hemangioendothelioma; Immunohistochemistry; IGF2BP3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Role of IMP3 and MYC Expression in the Classification of Postradiation Cutaneous Vascular Proliferations of the Breast
    Cornejo, Kristine
    Ayar, Sonali
    Oconnor, Ashling
    Kandil, Dina
    Moni, Janaki
    Dresser, Karen
    Deng, April
    Khan, Ashraf
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A283 - A283
  • [32] Immunohistochemical expression of IMP3 and p53 in inflammatory lesions and neoplastic lesions of the gastric mucosa
    Strehl, Johanna D.
    Hoegel, Josef
    Hornicek, Ines
    Hartmann, Arndt
    Riener, Marc-Oliver
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (05): : 2091 - 2101
  • [33] Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors
    Li, Lin
    Xu, Haodong
    Spaulding, Betsy O.
    Cheng, Liang
    Simon, Rochelle
    Yao, Jorge L.
    di Sant'Agnese, P. Anthony
    Bourne, Patricia A.
    Huang, Jiaoti
    HUMAN PATHOLOGY, 2008, 39 (08) : 1205 - 1211
  • [34] Super-Enhancer-Driven IGF2BP2 and IGF2BP3 Promote DDX21 Expression in Acute Myeloid Leukemia
    Zhao, Yanchun
    Jin, Jie
    BLOOD, 2023, 142
  • [35] Characterizing the Function of an RNA Binding Protein, IGF2BP3, in Hematopoiesis
    Tran, Tiffany M.
    Palanichamy, Jayanth Kumar
    Howard, Jonathan
    Contreras, Jorge R.
    Fernando, Thilini
    Basso, Giuseppe
    Pigazzi, Martina
    Sanford, Jeremy R.
    Rao, Dinesh S.
    BLOOD, 2015, 126 (23)
  • [36] Increased IGF2BP3 expression promotes the aggressive phenotypes of colorectal cancer cells in vitro and vivo
    Xu, Weimin
    Sheng, Yaru
    Guo, Yuegui
    Huang, Zhenyu
    Huang, Yiji
    Wen, Dongpeng
    Liu, Chen-Ying
    Cui, Long
    Yang, Yili
    Du, Peng
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (10) : 18466 - 18479
  • [37] The Diagnostic Utility of Hepatocyte Antigen, GPC3, and IMP3 in Distinguishing between Hepatocellular Carcinoma and Benign Hepatic Lesions
    Siadat, F.
    Nguyen, B. N.
    Gomes, M.
    Marginean, E. C.
    MODERN PATHOLOGY, 2011, 24 : 168A - 168A
  • [38] Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance
    Fadare, Oluwole
    Liang, Sharon X.
    Crispens, Marta A.
    Jones, Howard W., III
    Khabele, Dineo
    Gwin, Katja
    Zheng, Wenxin
    Mohammed, Khaled
    Parkash, Vinita
    Hecht, Jonathan L.
    Desouki, Mohamed M.
    HUMAN PATHOLOGY, 2013, 44 (08) : 1508 - 1515
  • [39] IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology
    Ikeda, Katsuhide
    Tate, Genshu
    Suzuki, Takao
    Kitamura, Takashi
    Mitsuya, Toshiyuki
    HUMAN PATHOLOGY, 2010, 41 (05) : 745 - 750
  • [40] IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes
    Rodriguez, S.
    Eiriksdottir, G.
    Gaunt, T. R.
    Harris, T. B.
    Launer, L. J.
    Gudnason, V.
    Day, I. N. M.
    GROWTH HORMONE & IGF RESEARCH, 2010, 20 (04) : 310 - 318
12345